Tennessee Gadolinium MRI Contrast Lawyer
Magnetic resonance imaging (MRI) scans are a common tool used by radiologists to take pictures of the human body to help in diagnosing various medical conditions such as cancer and internal bleeding. Radiologists often use a “contrast media” to help improve the quality of MRI scans. This is basically a dye injected into the patient’s body.
Gadolinium contrast media is one of the more common dyes used. But in recent years, there has been debate within the radiology community over the safety of Gadolinium-based agents. Indeed, many patients and their families have complained the dyes are toxic and that Gadolinium, a heavy metal, remains in the body long after the MRI is completed, despite assurances from the manufacturers that the agent naturally dissipates over time.
Excessive accumulation of gadolinium can lead to serious side effects. If you or a family member have experienced these effects following an MRI, a gadolinium contrast agent may be to blame. The lawyers at Fox & Farley in Tennessee can assist you in investigating your case and helping you decide whether legal action is necessary and appropriate.
FDA Issues New Guidelines in Response to Reports of Gadolinium Deposition Disease
On May 16, 2018, the U.S. Food and Drug Administration (FDA) approved new patient “Medication Guidelines” for all gadolinium contrast agents, including Dotarem, Eovist, Gadavist, Magnevist, MultiHance, Ominscan, OptiMARK, and ProHance. This comes on the heels of a December 2017 “Safety Announcement” warning healthcare professionals to advise their patients of the potential risks of gadolinium agents. Specifically, the FDA directed radiologists and related professionals to consider and disclose the risks of “gadolinium retention” following an MRI and take actions designed to “minimize problems.”
The FDA said doctors and patients need to carefully review the revised Medication Guidelines before using a gadolinium contrast agent under the following circumstances:
- The patient is pregnant or thinks she might be pregnant.
- The patient has required “multiple lifetime doses” of gadolinium contrast agents in the past.
- The patient is a child.
- The patient has an “inflammatory condition.”
- The patient has a history of kidney problems.
The FDA notes that in some cases, patients with pre-existing kidney failure may develop a “rare” condition known as a nephrogenic systemic fibrosis. Yet many other patients with previously normally functioning kidneys have also reported serious side effects due to gadolinium accumulation in the body. This is known as “gadolinium deposition disease,” and its symptoms include persistent headaches, bone and joint pain, and a burning sensation throughout the body.
The Gadolinium Agent Lawyers at Fox & Farley Can Help You
All drug manufacturers have a legal responsibility to ensure the safety of their products. If you have developed gadolinium deposition or disease or a similar condition as the result of using MRI agents, you may be entitled to compensation for your physical, mental, and emotional damages. The qualified Tennessee MRI contrast agent lawyers at Fox & Farley can sit down with you and assess your legal options. Call us today at 866-862-4855 to schedule a free, no-obligation consultation today.